SARS-CoV-2 Nucleocapsid anticorps
Aperçu rapide pour SARS-CoV-2 Nucleocapsid anticorps (ABIN6990088)
Antigène
Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Antibody recognizes 2019-nCoV Nucleocapsid Protein
-
Pureté
- 95,00%
-
Immunogène
- Cultured in vitro under conditions free from animal derived components.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 5.0 mg/mL
-
Buffer
- PBS, pH 7.4
-
Stock
- -20 °C,4 °C
-
Stockage commentaire
- 24 months from manufacturing at <-20 °C, 1 month, 2 to 8 °C under sterile conditions.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Autre désignation
- SARS-CoV-2 Nucleocapsid
-
Classe de substances
- Viral Protein
-
Sujet
- Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
-
ID gène
- 43740575
-
UniProt
- P0DTC9
Antigène
-